A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Ades, Lionel, Guerci-Bresler, Agnès, Cony-Makhoul, Pascale, Legros, Laurence, Sebert, Marie, Braun, Thorsten, Delaunay, Jacques, Desseaux, Kristell, Chevret, Sylvie, Fenaux, Pierre
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2019
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442966/
https://ncbi.nlm.nih.gov/pubmed/30381302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.203885
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados